From: Return to work after hospitalization for sepsis: a nationwide, registry-based cohort study
 | Sepsis, n (%) | Subgroups of sepsis | |
---|---|---|---|
ICU, n (%)a | Non-ICU, n (%)b | ||
Characteristics | 12 260(100) | n = 951 (7.8) | n = 11 309 (92.2) |
Male, n (%) | 7 341 (59.9) | 659 (69.3) | 6Â 682 (59.1) |
Age, years, mean (SD) | 43.7 (11.8) | 44.2 (11.8) | 43.7 (11.8) |
Age-group, n (%) | Â | Â | Â |
 18–29 | 2 077 (16.9) | 155 (16.3) | 1 922 (17.0) |
 30–39 | 2 314 (18.9) | 179 (18.8) | 2 135 (18.9) |
 40–49 | 3 121 (25.4) | 222 (23.3) | 2 899 (25.6) |
 50–60 | 4 748 (38.7) | 395 (41.5) | 4 353 (38.5) |
Comorbidities, n (%) | Â | Â | Â |
 Heart and vascular | 2 394 (19.5) | 383 (40.3) | 2 011 (17.8) |
 Cancer | 1 941 (15.8) | 44 (4.6) | 1 897 (16.8) |
 Lung | 681 (5.6) | 71 (7.5) | 610 (5.4) |
 Diabetes | 666 (5.4) | 81 (8.5) | 586 (5.2) |
 Immune | 269 (2.2) | 10 (1.1) | 259 (2.3) |
 Renal | 145 (1.2) | 8 (0.8) | 137 (1.2) |
 Liver | 44 (0.4) | 7 (0.7) | 37 (0.3) |
Number of comorbidities, n (%) | Â | Â | Â |
 0 | 7 290 (58.5) | 460 (48.4) | 6 830 (60.4) |
 1 | 3 933 (32.1) | 389 (40.9) | 3 544 (31.3) |
 2 | 911 (7.4) | 93 (9.8) | 818 (7.2) |
  ≥ 3 | 126 (1.0) | 9 (1.0) | 117 (1.0) |
Site of infection, n (%) | Â | Â | Â |
 Respiratory | 3 692 (30.2) | 498 (52.4) | 3 194 (28.2) |
 Genitourinary | 1 602 (13.1) | 87 (9.2) | 1 515 (13.4) |
 Skin and soft tissue | 558 (4.4) | 43 (4.5) | 515 (4.6) |
 Gastrointestinal | 827 (6.8) | 29 (3.1) | 624 (5.2) |
 Intra-abdominal | 755 (6.2) | 59 (6.2) | 696 (6.2) |
 Infections following a procedure | 625 (5.1) | 52 (5.5) | 573 (5.1) |
 Endocarditis/myocarditis | 190 (1.6) | 14 (1.5) | 176 (1.6) |
 Otherc | 2 056 (16.8) | 210 (22.1) | 1 846 (16.3) |
COVID-19-related sepsisd | 384 (3.1) | 39 (4.1) | 345 (3.1) |
Organ system with acute dysfunction, n (%) | Â | Â | Â |
 Respiratory | 3 063 (25.0) | 486 (51.0) | 2 578 (22.8) |
 Circulatory | 878 (7.2) | 243 (25.6) | 635 (5.6) |
 Renal | 2 627 (21.4) | 230 (24.2) | 2 397 (78.8) |
 Hepatic | 194 (1.6) | 31 (3.3) | 163 (1.4) |
 Coagulation | 757 (6.2) | 36 (3.8) | 721 (6.4) |
 Othere | 2 543 (20.7) | 293 (30.8) | 2 250 (19.9) |
Number of acute organ dysfunctions, n (%) | Â | Â | Â |
 1 | 6 422 (87.2) | 559 (63.8) | 5 675 (86.8) |
 2 | 736 (10.0) | 224 (25.6) | 656 (10.0) |
 3 | 164 (2.2) | 67 (7.7) | 146 (2.2) |
 ≥ 4 | 42 (0.6) | 26 (3.0) | 62 (1.0) |
Cause of ICU admission (n = 834), n (%) |  |  |  |
 Respiratory | NA | 173 (22.4) | NA |
 Circulatory | NA | 117 (15.1) | NA |
 Gastroenterological | NA | 38 (4.9) | NA |
 Neurological | NA | 87 (11.2) | NA |
 Sepsis | NA | 161 (20.8) | NA |
 Metabolic | NA | 32 (4.1) | NA |
 Renal | NA | 6 (0.8) | NA |
 Other | NA | 220 (20.7) | NA |
Illness severity at admission | Â | Â | Â |
 SAPS II, mean (SD) (n = 951) | NA | 33.4 (17.3) | NA |
 Invasive ventilation (n = 585), n (%) | NA | 485 (82.9) | NA |
Length of hospital stay in daysf, mean (SD) | 13.9 (23.7) | 25.4 (35.4) | 12.9 (22.2) |
30-day Readmissiong, n (%) | 3 664 (29.9) | 456 (47.8) | 3Â 208 (28.4) |